Shareholding disclosure

Novartis International AG

Declared position

5.7%

Threshold

Crossed upwards

Timeline

Published

29.10.2002

Transaction

—

Voting rights breakdown

Voting rights acquired5.7%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T1842D1814

Beneficial owner

Novartis International AG

Declared address

Novartis International, Basel

29.10.2002; Kotierungsprospekt

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Novartis International AG

Kuros Biosciences AG29.10.2002T1842D1814

Disclosure summary

Novartis International AG disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 29.10.2002, at 5.7% of voting rights. Notice category: Group of shareholders.

Disclosed position

5.7%

Voting rights acquired

Voting rights acquired5.7%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Novartis International AG disclosed a holding in Kuros Biosciences AG, published on 29.10.2002.

Publication date29.10.2002

Issuing companyKuros Biosciences AG

Beneficial ownerNovartis International AG

Declared addressNovartis International, Basel

CategoryGroup of shareholders

Voting rights acquired5.7%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT1842D1814

Commercial register

CHE-106.054.058

Registered

Zefix record

Conditions

29.10.2002; Kotierungsprospekt

Source: SIX Exchange Regulation · Publication date: 29.10.2002

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open